hormone

Glandokort

FDA: not-FDA-approved

Glandokort is a peptide bioregulator targeting adrenal cortex tissues. It helps normalize cortisol rhythms, enhance adrenal resilience, and improve energy during chronic fatigue or burnout states. Peptide bioregulator targeting adrenal cortex tissues. Helps normalize cortisol rhythms and enhance adrenal resilience. Improves energy during chronic fatigue or burnout states. Works epigenetically to support healthy adrenal function and stress hormone regulation. - Adrenal health and cortisol rhythm normalization - Stress resilience enhancement - Hormone balance support - Energy improvement during chronic fatigue - Burnout recovery support - Standard: 100-300 mcg SubQ 2-3x daily, usually pre-meal - Route: SubQ injection - Note: Should

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number
Route
02

Sourcing

Current prices

Updated today

Size unspecified

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Cortisol (AM)
DURING CYCLE
  • Cortisol (AM)
POST-CYCLE
  • CMP
  • Cortisol (AM)
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Glandokort may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.